Axogen (AXGN) Total Non-Current Liabilities (2017 - 2026)
Axogen (AXGN) recorded quarterly Total Non-Current Liabilities of $44.7 million in Q1 2026, down 49.77% quarter-over-quarter from $89.0 million in Q4 2025, and down 50.72% on a YoY basis from $90.7 million in Q1 2025.
Axogen (AXGN) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Axogen's Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $44.7 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 50.72% year-over-year to $44.7 million; the TTM figure through Mar 2026 stood at $44.7 million (down 50.72% YoY), while the FY2025 annual figure was $89.0 million, down 10.8% from the prior year.
- Total Non-Current Liabilities was $44.7 million for Q1 2026 at Axogen, down from $89.0 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $99.7 million in Q4 2024 to a low of $44.7 million in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $88.9 million across 5 years, with a median of $90.4 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities increased 18.26% in 2022, then tumbled 50.72% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $89.9 million in 2022, then advanced by 9.24% to $98.2 million in 2023, then rose by 1.58% to $99.7 million in 2024, then retreated by 10.8% to $89.0 million in 2025, then sank by 49.77% to $44.7 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $44.7 million (Q1 2026), $89.0 million (Q4 2025), and $93.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn | 44.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.68 Mn |
| Dec 31, 2025 | 88.95 Mn |
| Sep 30, 2025 | 93.73 Mn |
| Jun 30, 2025 | 93.04 Mn |
| Mar 31, 2025 | 90.66 Mn |
| Dec 31, 2024 | 99.73 Mn |
| Sep 30, 2024 | 92.48 Mn |
| Jun 30, 2024 | 90.79 Mn |
| Mar 31, 2024 | 90.44 Mn |
| Dec 31, 2023 | 98.18 Mn |
| Sep 30, 2023 | 92.95 Mn |
| Jun 30, 2023 | 90.22 Mn |
| Mar 31, 2023 | 87.26 Mn |
| Dec 31, 2022 | 89.87 Mn |
| Sep 30, 2022 | 89.67 Mn |
| Jun 30, 2022 | 89.52 Mn |
| Mar 31, 2022 | 88.86 Mn |
| Dec 31, 2021 | 89.91 Mn |
| Sep 30, 2021 | 90.87 Mn |
| Jun 30, 2021 | 89.87 Mn |